Abstract 10118: PCSK9 Inhibition Augments the Therapeutic Effect of Ezetimibe in Lowering Intestinal Apolipoprotein B Lipoprotein Production
2013
Ezetimibeis an effective therapy to lower circulating
low-density lipoprotein(LDL) cholesterol, a maneuver expected to reduce coronary heart disease (CHD) risk. However,
ezetimibeconcomitantly r...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI